PDS Biotechnology price target lowered to $3 from $5 at B. Riley

B. Riley lowered the firm’s price target connected PDS Biotechnology (PDSB) to $3 from $5 and keeps a Buy standing connected the shares. The shares stay attractively valued with near-zero EV that fails to bespeak interaction of this caller strategical pivot connected enrollment size, efficacy endpoint durations and an enriched p16+ve colonisation with constricted competing trials, the expert tells investors successful a probe note.

TipRanks Black Friday Sale

• Claim 60% disconnected TipRanks Premium for the data-backed insights and probe tools you request to put with confidence.

• Subscribe to TipRanks' Smart Investor Picks and spot our information successful enactment done our high-performing exemplary portfolio - present besides 60% disconnected

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See Insiders’ Hot Stocks connected TipRanks >>

Read More connected PDSB:

Disclaimer & DisclosureReport an Issue

• VTI ETF Daily Report—11/20/2025

• PDS Biotechnology: Promising Trial Results and Financial Update

• PDS Biotechnology’s Earnings Call: Clinical Wins Amid Financial Hurdles

• PDS Biotechnology terms people raised to $15 from $13 astatine H.C. Wainwright

• PDS Biotechnology reports Q3 EPS (19c), statement (20c)